The stock's fall snapped a two-day winning streak.

"Carelon Services delivered strong results with CareBridge scaling rapidly across dual eligible and high-acuity Medicaid ...

Elevance Health faced a tough crowd as it revealed its Q2 results. Despite a revenue jump to $49.4 billion, up 14% from last year, the adjusted EPS of $8.84 missed the mark by $0.23 according to ...

A digital intervention using the Apple Watch helped people on Medicaid better control their asthma, illustrating the ...

Elevance Health (ELV) just surged a massive 191% in trading volume, turning heads in the stock market. On July 22, 2025, the ...

Argus has downgraded Elevance Health to hold from buy citing pressure on profit margins due to higher medical cost trends in its ACA marketplace and Medicaid businesses.

The Indianapolis-based company said it had net income of $7.72 per share. Earnings, adjusted for one-time gains and costs, came to $8.84 per share. The results did not meet Wall Street expectations.

LOS ANGELES, July 10, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Elevance ...

Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit By The Law Offices of Frank R. Cruz, Los Angeles Jun 20, 2025 Updated 2 mins ago ...

Elevance Health, Inc. (ELV) reaffirms 2025 EPS guidance and reports strong Q1 performance, despite Medicare audit concerns. ELV stock up 6.39% premarket.

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. Lead plaintiff motions for the Elevance Health ...

Today, Benzinga's options scanner identified 10 options transactions for Elevance Health. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 10% being ...